Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A

British Journal of Cancer

Volumn 64, Issue 6, 1991, Pages 1047-1050

  Grandi, M ^a   Biasoli, G ^a   Capolongo, L ^a   Ballinari, D ^a   Barbieri, B ^a   Pastori, A ^a   Pesenti, E ^a   Mongelli, N ^a   Spreafico, F ^a   Pezzoni, G ^b   Giuliani, F C ^b  

^a Erbamont Group ^*  (Italy)

^b Boehringer Mannheim Italia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DISTAMYCIN A; DOXORUBICIN; MELPHALAN; TALLIMUSTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; COLON CARCINOMA; DRUG ACTIVITY; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA L 1210; LUNG SMALL CELL CANCER; MALE; MELANOMA; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; SOLID TUMOR; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL SURVIVAL; DISTAMYCINS; IN VITRO; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NITROGEN MUSTARD COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0026322735     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1991.463     Document Type: Article

References (19)

1. ARCAMONE, F., PENCO, S., OREZZI, P., NICOLELLA, V. & PIRELLI, A. (1964). Structure and synthesis of Distamycin A. Nature, 203, 1064
2. ARCAMONE, F., ANIMATI, F., BARBIERI, B. & 9 others (1989). Synthesis, DNA-binding properties, and antitumor activity of novel Distamycin derivatives. J. Med. Chem., 32, 11 A
3. BALLINARI, D., RADICE, P., GRANDI, M. & 5 others (1988). MDR amplification and karyotypic analysis of anthracycline-resistant human tumor cell lines. Cancer Commun., 3, 69
4. BROGGINI, M, PONTI, M., OTTOLENGHI, S., DTNCALCI, M., MONGELLI, N. & MANTOVANI, R. (1989). Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res., 17, 1051
5. BROGGINI, M., ERBA, E., PONTI, M., BALLINARI, D., GERONI, C., SPREAFICO, F. & D’INCALCI, M. (1991). Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res., 51, 199
6. CASAZZA, A M., FIORETTI, A., GHIONE, M., SOLDATI, M. & VERINI, M.A. (1985). Distamycin A, a new antiviral antibiotic. Antimicrob. Agents Chemother., 1985, 593
7. CORBETT, T.H., ROBERTS, B.J., LEOPOLD, W.R. & 4 others (1984). Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res., 44, 717
8. Dl MARCO, A., GAETANI, M., OREZZI, P., SCOTTI, T. & ARCAMONE, F. (1962). Experimental studies on Distamycin A. A new antibiotic with cytotoxic activity. Cancer Chemother. Rep., 18, 15
9. Dl MARCO, A., LENAZ, L., CASAZZA, A M. & SCARPINATO, B.M. (1972). Activity of Adriamycin (NSC-123127) and Daunorubicin (NSC-82151) against mouse mammary carcinoma. Cancer Chemother. Rep., 56, 153
10. DREWINKO, B., ROMSDAHL, M.M., YANG, L.Y., AHEARN, M.J. & TRUJILLO, J.M. (1976). Establishment of a human carcinoembryonic antigen - producing colon adenocarcinoma cell line. Cancer Res., 36, 467
11. GERAN, R.I., GREENBERG, N.H., MACDONALD, M.M., SCHUMAKER, A.M. & ABBOT, B.J. (1972). Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep., 3, 1
12. GRANDI, M., GERONI, C. & GIULIANI, F.C. (1986). Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin. Short communication. Br. J. Cancer, 54, 515
13. GRINDEY, G.B. (1990). Current status of cancer drug development: failure or limited success? Cancer Cells, 2, 163
14. KOPKA, M.L., YOON, CH., GOODSELL, D., PJURA, PH. & DICKERSON, E. (1985). The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl Acad. Sci., 82, 1376
15. MONTECUCCO, A., FONTANA, M., FOCHER, F., LESTINGI, M., SPADARI, S. & CIARROCCHI, G. (1991). Specific inhibition of human DNA ligase adenylation by aderivative possessing antitumor activity. Nucleic Acids Res., 19, 1067
16. NATALI, P.G., SEGATTO, O., ZUPI, G., CAVALIERE, R., GIACOMINI, P. & FERRONE, S. (1983). Isolation of viable melanoma cells from surgically removed lesions using dishes coated with monoclonal antibody to a high molecular weight melanoma associated antigen. J. Immunol. Methods, 62, 337
17. STAQUET, M.J., BYAR, D.P., GREEN, S.B. & ROZENCWEIG, M. (1983). Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy. Cancer Treat. Rep., 67, 753
18. ZACCHEO, T., BELLINI, O. , GERONI, C. & GIULIANI, F.C. (1986). Characterization of murine sarcoma with low sensitivity to doxorubicin. Abst. of the 14th International Cancer Congress, 1, No. 2608
19. ZIMMER, C. & WAHNERT, V. (1986). Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigation of the genetic material. Prog. Biophys. Mol. Biol., 47, 31